Showing results (1-10 of 638) with videos related to

Sort By:
Pageof 64
Expert Review of Hematology|July 12, 2012
Diagnosis, progression patterns and prognostication in mastocytosisWolfgang R Sperr, Peter Valent
Blood|September 22, 2010
How I treat patients with advanced systemic mastocytosisPeter Valent, Wolfgang R Sperr, Cem Akin
International Archives of Allergy and Immunology|March 29, 2002
Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosisWolfgang R Sperr, Hans-Peter Horny, Peter Valent
Leukemia & Lymphoma|March 5, 2003
Tryptase a novel biochemical marker of acute myeloid leukemiaWolfgang R Sperr, Alexander W Hauswirth, Peter Valent
Leukemia & Lymphoma|August 9, 2005
CD 33 as a target of therapy in acute myeloid leukemia: current status and future perspectivesWolfgang R Sperr, Stefan Florian, Alexander W Hauswirth, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2004
Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasmsPeter Valent, Wolfgang R Sperr, Lawrence B Schwartz, et al.
Oncotarget|September 2, 2016
Evaluation of in vitro effects of various targeted drugs on plasma cells and putative neoplastic stem cells in patients with multiple myelomaKatharina Blatt, Harald Herrmann, Gabriele Stefanzl, et al.
Wiener Klinische Wochenschrift|September 19, 2003
Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS)Peter Valent, Friedrich Wimazal, Ilse Schwarzinger, et al.
International Archives of Allergy and Immunology|November 30, 2011
Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experienceFriedrich Wimazal, Philipp Geissler, Patrik Shnawa, et al.
Blood|October 24, 2002
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycinMatthias Mayerhofer, Peter Valent, Wolfgang R Sperr, et al.
Pageof 64